Stocks and InvestingStocks and Investing
Wed, May 11, 2022
Tue, May 10, 2022

Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $30 on, May 10th, 2022


Published on 2024-10-27 20:58:49 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $34 to $30 on, May 10th, 2022.

Gregory has made no other calls on ADCT in the last 4 months.



There is 1 other peer that has a rating on ADCT. Out of the 1 peers that are also analyzing ADCT, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $54 on, Friday, March 4th, 2022